NDC 55111-447 – Fexofenadine HCl and Pseudoephedrine HCI

Fexofenadine Hydrochloride 60 mg/1; Pseudoephedrine Hydrochloride 120 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC55111-447

Product details

Brand name
Fexofenadine HCl and Pseudoephedrine HCI
Generic name
Fexofenadine HCl and Pseudoephedrine HCI
Labeler
Dr. Reddy's Laboratories Limited
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA076667
Marketed since
November 18, 2014
Listing expires
December 31, 2026
Pharmacologic class
Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Fexofenadine HCl and Pseudoephedrine HCI →

Package NDC codes (3)

Package NDCDescriptionSince
55111-447-144 BLISTER PACK in 1 CARTON (55111-447-14) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (55111-447-07)Nov 18, 2014
55111-447-316 BLISTER PACK in 1 CARTON (55111-447-31) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (55111-447-07)Nov 18, 2014
55111-447-352 BLISTER PACK in 1 CARTON (55111-447-35) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (55111-447-07)Nov 18, 2014

Other Fexofenadine HCl and Pseudoephedrine HCI products